Back to the main directory
Earnings/Financial Statement / Equity
- TEX: The Powers That MP by Credit Suisse
- X: Deep Value Trading Below 2.0x EV/EBITDA on Both 2022+23; Capital Return Just Starting by Credit Suisse
- EPRT: Earnings Beat; AFFO Guidance for FY21 Reaffirmed, FY22 Range Established with 13.0% Growth at the Midpoint by Credit Suisse
- CACC: 3Q - Originations and spreads weaker, offset by strong buyback and credit - Collections likely to moderate by Credit Suisse
- TSKB.IS: TSKB - Q3 21 - A beat driven by NII and net provisions by Credit Suisse
- SBAC: 3Q21 Results - Beat & Raise; Strong 2022 Commentary Bolsters Our View; Positives on DISH, T, 3.45 GHz by Credit Suisse
- TRI: Beat + raise in a transformation = outperform by Credit Suisse
- EPD: Record Petchem Results; Capex Holds Steady by Credit Suisse
- NYMT: Stable Book Value, Portfolio Runoff Limits Growth in Net Interest Income by Credit Suisse
- ESPR: Q3 Earnings - Focus Shifts to Funding the CVOT by Credit Suisse
- GPN: Q3 2021 Recap; Updated Benchmarking Analysis vs. Card Networks by Credit Suisse
- NXPI: Don't Miss the xEV Forest Thru the Cyclical Trees by Credit Suisse
- OKE: Beat and Raise Quarter by Credit Suisse
- RDN: NIW Drives Faster IIF Growth, Premium Yield Decline Continues by Credit Suisse
- EARN: Lower Net Interest Spread Drives EPS Miss, Book Value Below Expectations by Credit Suisse
- ROK: Upsized FY22 EPS Guide Out of the Gate - FQ421 Recap by Credit Suisse
- VOYA: Initial Read: Solid 3Q21 Results and Underlying Trends by Credit Suisse
- PRU: 3Q21 EPS Beat on Variable Investment Income; Solid Underlying Results Excluding COVID by Credit Suisse
- UNM: 3Q21 Earnings Miss on Elevated COVID-19 Claims in Group Life by Credit Suisse
- COLOb.CO: Coloplast B - Q4 and FY22 guidance show reliable growth patterns by Credit Suisse
- MDLZ: 3Q Gross Profits Allay Market Concerns and 2022 Outlook Looks Robust by Credit Suisse
- EL: With Americas and EMEA Already Strong, China Getting Ready to Re-Join the Party by Credit Suisse
- ACRE: Strong Portfolio Growth, Better REO Performance Drives Upside by Credit Suisse
- CVS: Q3 EPS $0.18 Above Estimates on Retail/PBM Outperformance; Raising 2021 Outlook by Credit Suisse
- HUM: 3Q21 Slightly Above Consensus, 2021 Adj. EPS Outlook Reduced on Conservative 4Q; 2021 Jumping Off EPS Baseline Confirmed at $21.50 by Credit Suisse